Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell of proximal tubule | 6 studies | 26% ± 7% | |
epithelial cell | 6 studies | 29% ± 12% |
Insufficient scRNA-seq data for expression of FAHD1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1137.36 | 1445 / 1445 | 100% | 27.93 | 183 / 183 |
kidney | 100% | 3350.79 | 89 / 89 | 100% | 84.25 | 901 / 901 |
liver | 100% | 1964.78 | 226 / 226 | 100% | 59.86 | 406 / 406 |
thymus | 100% | 707.60 | 653 / 653 | 100% | 29.96 | 604 / 605 |
bladder | 100% | 973.81 | 21 / 21 | 100% | 33.64 | 503 / 504 |
breast | 100% | 845.93 | 459 / 459 | 100% | 41.93 | 1115 / 1118 |
stomach | 100% | 907.64 | 358 / 359 | 100% | 36.57 | 286 / 286 |
skin | 100% | 1573.35 | 1808 / 1809 | 100% | 39.50 | 470 / 472 |
intestine | 100% | 1534.36 | 965 / 966 | 100% | 40.35 | 525 / 527 |
ovary | 99% | 547.25 | 179 / 180 | 100% | 25.66 | 430 / 430 |
prostate | 100% | 848.68 | 245 / 245 | 99% | 32.04 | 497 / 502 |
uterus | 99% | 681.03 | 169 / 170 | 100% | 31.72 | 457 / 459 |
brain | 99% | 862.76 | 2608 / 2642 | 100% | 30.04 | 705 / 705 |
adrenal gland | 100% | 1752.19 | 258 / 258 | 98% | 39.11 | 226 / 230 |
pancreas | 98% | 572.94 | 323 / 328 | 99% | 29.55 | 177 / 178 |
lung | 92% | 662.71 | 534 / 578 | 100% | 29.28 | 1155 / 1155 |
adipose | 100% | 915.63 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.95 | 29 / 29 |
spleen | 100% | 688.63 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 28.93 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 41.06 | 1 / 1 |
muscle | 100% | 1054.39 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 679.70 | 1328 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 34.02 | 77 / 80 |
heart | 94% | 1014.48 | 811 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 80% | 413.74 | 741 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006090 | Biological process | pyruvate metabolic process |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0018773 | Molecular function | acetylpyruvate hydrolase activity |
GO_0047621 | Molecular function | acylpyruvate hydrolase activity |
GO_0008948 | Molecular function | oxaloacetate decarboxylase activity |
GO_0034545 | Molecular function | fumarylpyruvate hydrolase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | FAHD1 |
Protein name | Acylpyruvase FAHD1, mitochondrial (EC 3.7.1.5) (Fumarylacetoacetate hydrolase domain-containing protein 1) (FAH domain-containing protein 1) (Oxaloacetate decarboxylase) (OAA decarboxylase) (EC 4.1.1.112) (YisK-like protein) |
Synonyms | YISKL C16orf36 |
Description | FUNCTION: Probable mitochondrial acylpyruvase which is able to hydrolyze acetylpyruvate and fumarylpyruvate in vitro . Also has oxaloacetate decarboxylase activity . . |
Accessions | ENST00000382666.6 Q6P587 ENST00000382668.8 ENST00000427358.5 |